Načítá se...
Therapeutic gene editing in CD34(+) hematopoietic progenitors from Fanconi anemia patients
Gene targeting constitutes a new step in the development of gene therapy for inherited diseases. Although previous studies have shown the feasibility of editing fibroblasts from Fanconi anemia (FA) patients, here we aimed at conducting therapeutic gene editing in clinically relevant cells, such as h...
Uloženo v:
| Vydáno v: | EMBO Mol Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5666315/ https://ncbi.nlm.nih.gov/pubmed/28899930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201707540 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|